Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Associations between serum lipids and hepatitis C antiviral treatment efficacy.

Hepatology (Baltimore, Md.) - 1 Sept 2010

Ramcharran Darmendra, Wahed Abdus S, Conjeevaram Hari S, Evans Rhobert W, Wang Tianyi, Belle Steven H, Yee Leland J

Abstract excerpt

UNLABELLED: Approximately one half of patients who undergo antiviral therapy for chronic hepatitis C virus (HCV) genotype 1 infection do not respond to treatment. African Americans (AAs) are less responsive to treatment than Caucasian Americans (CAs), but the reasons for this disparity are largely unknown. Recent studies suggest that serum lipids may be associated with treatment response. The aims of this study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol, HDL
Share to Cholesterol, LDL

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Lipids

Share to Polyethylene Glycols

Share to Ribavirin

Share to Triglycerides

Source

Open in PubMed Open full text

Identifiers

PMID: 20690192
DOI: 10.1002/hep.23796
PMCID: PMC2938827

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Associations between serum lipids and hepatitis C antiviral treatment efficacy.PMID 20690192Read ↗

Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort.Semantic proximity Read ↗

Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy.Semantic proximity Read ↗

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.Semantic proximity Read ↗

The impact of ethnicity on hepatitis C virus treatment decisions and outcomes.Semantic proximity Read ↗

Sustained virological response rate to pegylated interferon plus ribavirin for chronic hepatitis C in African Americans: results in treatment-naïve patients in a university liver clinic.Semantic proximity Read ↗

Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection.Semantic proximity Read ↗

Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.Semantic proximity Read ↗

Vitamin D and the racial difference in the genotype 1 chronic hepatitis C treatment response.Semantic proximity Read ↗

Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment.Semantic proximity Read ↗

Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response.Semantic proximity Read ↗

Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients.Semantic proximity Read ↗

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.